Your session is about to expire
← Back to Search
Prehabilitation Exercise for Ovarian Cancer
N/A
Recruiting
Led By Scott Grandy, PhD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have a confirmed diagnosis of stage III or IV ovarian cancer
18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, about 2 years
Awards & highlights
Study Summary
This trialwill explore whether an exercise program before surgery can improve survival for women with advanced ovarian cancer. It will look at how it affects frailty, recovery and treatment.
Who is the study for?
This trial is for English-speaking adults over 18 with stage III or IV ovarian cancer, who are approved by their oncologist to join. They must be scheduled for cytoreductive surgery with at least a 4-week gap before the operation and able to attend exercise sessions. Those with unstable heart/lung disease, significant cognitive issues, or post-surgery status cannot participate.Check my eligibility
What is being tested?
The study tests if a prehabilitation exercise program (like walking, chair exercises) can reduce frailty in patients awaiting surgery for advanced ovarian cancer. It aims to see if this improves recovery after surgery and affects chemotherapy treatment plans.See study design
What are the potential side effects?
While not explicitly stated, potential side effects of the prehabilitation exercise could include typical risks associated with physical activity such as muscle soreness, fatigue, and in rare cases injury; however these are generally low-risk activities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with stage III or IV ovarian cancer.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, about 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, about 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Chemotherapy completion rates (End of Cycle 1)
Chemotherapy completion rates (End of Cycle 2)
Chemotherapy completion rates (End of Cycle 3)
+9 moreSecondary outcome measures
Aerobic Fitness Change (baseline to 1-month post surgery)
Aerobic Fitness Change (baseline to 3-months post surgery)
Aerobic Fitness Change (baseline to post exercise intervention)
+12 moreOther outcome measures
Adverse Events
Study Feasibility - Participant Accrual
Study Feasibility - Participant Adherence
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Circuit-based prehabilitation exercise intervention
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
258 Previous Clinical Trials
83,746 Total Patients Enrolled
Dalhousie UniversityOTHER
167 Previous Clinical Trials
403,030 Total Patients Enrolled
Scott Grandy, PhDPrincipal InvestigatorNova Scotia Health
2 Previous Clinical Trials
36 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My surgery is scheduled at least 4 weeks after joining the study.I can understand and follow instructions.I can attend exercise sessions, either in-person or online.I have been diagnosed with stage III or IV ovarian cancer.I am 18 years old or older.I do not have any heart, lung, or other serious health issues that make exercising unsafe for me.I have completed my surgery.I am scheduled for surgery to remove as much of my cancer as possible.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the maximum enrollment capacity for this clinical trial?
"Affirmative. According to information hosted on clinicaltrials.gov, this scientific experiment is still searching for participants and was initially posted on the 3rd of January in 2023. The study has been recently updated as of February 6th 2021 and requires 108 volunteers from one site."
Answered by AI
Is this research endeavor actively recruiting participants?
"Indeed, records on clinicaltrials.gov demonstrate that this experiment is currently recruiting participants. It was initially posted on March 1st 2023 and most recently updated February 6th 2023; it aims to enrol 108 individuals from a single site."
Answered by AI
What are the stated aims of this medical experiment?
"This medical experiment will track the primary outcome of chemotherapy completion rates at the end of cycle 4, with follow-up measurements occurring shortly after. Additionally, secondary metrics to be assessed include body mass index changes from baseline up to 1 month and 3 months post operation (calculated using weight in kg and height in m)."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger